✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹138 Cr.
P/E
17.21

Key Ratios

Market cap
Market cap
138 Cr
PE
PE
17.21
Prom Holding
Prom Holding
72.85 %
ROE (%)
ROE (%)
9.46
ROCE (%)
ROCE (%)
9.86
Div Yield (%)
Div Yield (%)
-
Sales
Sales
95.61 Cr
OPM (%)
OPM (%)
9.66 %
Debt to Equity
Debt to Equity
0.55
About
Sotac Pharmaceuticals Limited specializes in the production of high-quality pharmaceutical pro… Read more
Low
88
52W Range
High
170
  • Sotac Pharmaceutical
  • Denis Chem Lab
  • Mangalam Drugs&Org.

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

3 Neutral

Neutral for this company

5 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Peer Comparison
FAQs on Sotac Pharmaceuticals Ltd. Business

Sotac Pharmaceuticals Limited offers high-quality pharmaceutical, nutraceutical, and food products through loan license or contract manufacturing. They serve corporate clients in this sector.

Sotac Pharmaceutical major competitors are Denis Chem Lab, Mangalam Drugs&Org., Tyche Inds, Parnax Lab, Murae Organisor, Lactose India, Smruthi Organics.
Market Cap of Sotac Pharmaceutical is ₹138 Crs.
While the median market cap of its peers are ₹140 Crs.

Sotac Pharmaceutical seems to be less financially stable compared to its competitors.
Altman Z score of Sotac Pharmaceutical is 3.26 and is ranked 5 out of its 8 competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material